The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity Disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,639
Handbook of Autism and Pervasive Developmental Disorders
(2005) · Wiley eBooks · doi:10.1002/9780470939352 · Cited by 2,250
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Journal of Abnormal Child Psychology · doi:10.1007/bf00919127 · Cited by 1,720
Diagnostic and Statistical Manual of Mental Disorder
Ellsworth, P. D. (1980) · The American Journal of Occupational Therapy · doi:10.5014/ajot.34.12.819a · Cited by 1,700
Hyperactivity, inattention, and aggression in clinical practice
Milich, R. S., & Loney, J. (1982) · UKnowledge (University of Kentucky) · Cited by 533
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Multivariate Statistics in the Social Sciences: A Researcher's Guide.
Bingham, C., Marascuilo, L. A., & Levin, J. R. (1985) · Journal of the American Statistical Association · doi:10.2307/2288090 · Cited by 287
Use of methylphenidate in the treatment of children with autistic disorder
Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02179289 · Cited by 217
Research works printed but not linked: 4
- Aman, M. G., & Singh, N. (1986). The Aberrant Behavior Checklist. East Aurora, NY: Slosson.
- DuPaul, G. J., & Barkley, R. A. (1990). Medication therapy. In R. A. Barkley (ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (pp. 573–612). New York: Guilford.
- Schopler, E., Reichler, R. J., & Renner, B. R. (1988). The Childhood Autism Rating Scale. Los Angeles, CA: Western Psychological Services.
- Volkmar, F. R., Klin, A., Marans, W., & McDougle, M. D. (1996). Autistic disorder. In F. R. Volkmar (Ed.), Psychoses and pervasive developmental disorders in childhood and adolescence (pp. 129–190). Washington DC: American Psychiatric Press.
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Self-citationEvidence-Based Comprehensive Treatments for Early Autism
Rogers, S. J., & Vismara, L. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701817808 · Cited by 984
Autism and the pervasive developmental disorders
Volkmar, F. R., & Klin, A. (2012) · New Oxford Textbook of Psychiatry · doi:10.1093/med/9780199696758.003.0214 · Cited by 939
Volkmar, F., Siegel, M., Woodbury-Smith, M., King, B., McCracken, J., & State, M. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.10.013 · Cited by 848
Autism Spectrum Disorder: Classification, diagnosis and therapy
Sharma, S. R., Gonda, X., & Tarazi, F. I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.007 · Cited by 673
Autism and pervasive developmental disorders
Volkmar, F. R., Lord, C., Bailey, A., Schultz, R. T., & Klin, A. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1046/j.0021-9630.2003.00317.x · Cited by 616
Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder
Rommelse, N. N. J., Franke, B., Geurts, H. M., Hartman, C. A., & Buitelaar, J. K. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0092-x · Cited by 564
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
“The finding of increased social withdrawal with higher doses of methylphenidate is consistent with adverse events described in previous studies.(9) Methylphenidate treatment was associated with an 18% rate of discontinuation owing to adverse events.”
ResultMayes, S. D., & Calhoun, S. L. (2007) · Child Neuropsychology · doi:10.1080/09297040601112773 · Cited by 420
Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek, A., Kotte, A., Stevens, J., Furtak, S. L., Bourgeois, M., et al. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1679-5 · Cited by 419
WISC-IV and WIAT-II Profiles in Children With High-Functioning Autism
Mayes, S. D., & Calhoun, S. L. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0410-4 · Cited by 331
FARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325
“Clinically, over one third of patients with ASD meet criteria for symptoms of ADHD, which is true of several of our probands.(66,67) However, to preserve consistency with the DSM-IV-TR, we have labeled these individuals as having symptoms of ADHD instead of a specifying diagnosis of ADHD.”
BackgroundMayes, S. D., & Calhoun, S. L. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1024462719081 · Cited by 319
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Psychiatric Symptoms in Preschool Children with PDD and Clinic and Comparison Samples
Gadow, K. D., DeVincent, C. J., Pomeroy, J., & Azizian, A. (2004) · Journal of Autism and Developmental Disorders · doi:10.1023/b:jadd.0000037415.21458.93 · Cited by 295
Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., Coury, D., Whitaker, A., Veenstra-Vanderweele, J., & Hardan, A. Y. (2016) · Pediatrics · doi:10.1542/peds.2015-2851k · Cited by 294
Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800802 · Cited by 285
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial
ARNOLD, L. E., AMAN, M. G., COOK, A. M., WITWER, A. N., HALL, K. L., THOMPSON, S., & RAMADAN, Y. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000231976.28719.2a · Cited by 260
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00304 · Cited by 260
Brieber, S., Neufang, S., Bruning, N., Kamp‐Becker, I., Remschmidt, H., Herpertz‐Dahlmann, B., Fink, G. R., & Konrad, K. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01799.x · Cited by 253
Autism and ADHD: how far have we come in the comorbidity debate
Gargaro, B. A., Rinehart, N. J., Bradshaw, J. L., Tonge, B. J., & Sheppard, D. M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.11.002 · Cited by 244
Smalley, S. L., Kustanovich, V., Minassian, S. L., Stone, J. L., Ogdie, M. N., McGough, J. J., McCracken, J. T., MacPhie, I. L., Francks, C., Fisher, S. E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342732 · Cited by 240
ADHD symptom subtypes in children with pervasive developmental disorder
Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-0060-3 · Cited by 233
Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment
Reiersen, A. M., & Todd, R. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.657 · Cited by 189
Attention-deficit/hyperactivity disorder in the context of autism spectrum disorders
Murray, M. J. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0145-3 · Cited by 185
Pharmacological therapies for autism spectrum disorder: a review.
(2015) · PubMed Central · Cited by 150
The comorbidity of ADHD and autism spectrum disorder
Antshel, K. M., Zhang-James, Y., & Faraone, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.840417 · Cited by 147
Handen, B. L., Aman, M. G., Arnold, L. E., Hyman, S. L., Tumuluru, R. V., Lecavalier, L., Corbett-Dick, P., Pan, X., Hollway, J. A., Buchan-Page, K. A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.013 · Cited by 147
Self-citationJahromi, L. B., Kasari, C. L., McCracken, J. T., Lee, L. S.-Y., Aman, M. G., McDougle, C. J., Scahill, L., Tierney, E., Eugene Arnold, L., Vitiello, B., et al. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0636-9 · Cited by 144
Methylphenidate for children and adolescents with autism spectrum disorder
Sturman, N., Deckx, L., & van Driel, M. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011144.pub2 · Cited by 135
Reichow, B., Volkmar, F. R., & Bloch, M. H. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1793-z · Cited by 134
Posey, D. J., Aman, M. G., McCracken, J. T., Scahill, L., Tierney, E., Arnold, L. E., Vitiello, B., Chuang, S. Z., Davies, M., Ramadan, Y., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.028 · Cited by 131
Posey, D. J., Puntney, J. I., Sasher, T. M., Kem, D. L., & McDougle, C. J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649084 · Cited by 127
“Subsequent studies of methylphenidate conducted in small samples encouraging (Quintana et al. 1995; Handen et al. 2000), but have raised questions about the magnitude of benefit and tolerability.”
Guanfacine in children with autism and/or intellectual disabilities
Handen, B. L., Sahl, R., & Hardan, A. Y. (2008) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181739b9d · Cited by 126
Self-citationMatson, J. L., Rieske, R. D., & Williams, L. W. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2013.05.021 · Cited by 124
Posey, D. J., Wiegand, R. E., Wilkerson, J., Maynard, M., Stigler, K. A., & McDougle, C. J. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.599 · Cited by 117
Simonoff, E., Taylor, E., Baird, G., Bernard, S., Chadwick, O., Liang, H., Whitwell, S., Riemer, K., Sharma, K., Sharma, S. P., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02569.x · Cited by 115
“…McMurray, Edelbrock, and Robbins, 1992) suggest that those with autism may be particularly sensitive to adverse effects s and prone to develop more tics, rituals/compulsions, stereotyped behaviours, irritability and social withdrawal (Handen, Johnson, and Lubetsky, 2000; Quintana, et al., 1995).”
BackgroundMayes, S. D., & Calhoun, S. L. (2004) · The Clinical Neuropsychologist · doi:10.1080/13854040490888530 · Cited by 105
van de Loo-Neus, G. H. H., Rommelse, N., & Buitelaar, J. K. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.008 · Cited by 98
Rodrigues, R., Lai, M., Beswick, A., Gorman, D. A., Anagnostou, E., Szatmari, P., Anderson, K. K., & Ameis, S. H. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13305 · Cited by 98
Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders
Aman, M. G., Farmer, C. A., Hollway, J., & Arnold, L. E. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.06.009 · Cited by 82
Di Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649011 · Cited by 82
“The total score and the 3 domains “Social Impairment,” “Negative Emotions,” and “Distorted Sensory Response”), as characterized by DiLalla et al. (DiLalla and Rogers 63-item rating scale, 28 of which are based on the direct observation of patients.”
InfluentialTreatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys
Torrioli, M., Vernacotola, S., Setini, C., Bevilacqua, F., Martinelli, D., Snape, M., Hutchison, J. A., Di Raimo, F. R., Tabolacci, E., & Neri, G. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33484 · Cited by 71
Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder
Hazell, P. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.00995.x · Cited by 69
Stimulant Medication Treatment of Target Behaviors in Children with Autism: A Population-Based Study
Nickels, K. C., Katusic, S. K., Colligan, R. C., Weaver, A. L., Voigt, R. G., & Barbaresi, W. J. (2008) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31815f24f7 · Cited by 51
Motaghinejad, M., Motevalian, M., Shabab, B., & Fatima, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1623-5 · Cited by 46
“and non-pharmacologic levels remain unclear (Handen et al. 2000).”
BackgroundCharnsil, C. (2011) · Journal of Attention Disorders · doi:10.1177/1087054710376907 · Cited by 36
Toward Quality Care in ADHD: Defining the Goals of Treatment
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712473835 · Cited by 33
Psychopharmacology of Autism Spectrum Disorder
Siegel, M. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.006 · Cited by 27
Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder
Handen, B. L., Taylor, J., & Tumuluru, R. (2011) · ijamh · doi:10.1515/ijamh.2011.039 · Cited by 26
Self-citationMurphy, D., Glaser, K., Hayward, H., Eklund, H., Cadman, T., Findon, J., Woodhouse, E., Ashwood, K., Beecham, J., Bolton, P., et al. (2018) · Programme Grants for Applied Research · doi:10.3310/pgfar06020 · Cited by 18
Sinzig, J., & Lehmkuhl, G. (2007) · Psychopathology · doi:10.1159/000105531 · Cited by 14
Lilja, M. M., Sandblom, E., Lichtenstein, P., Serlachius, E., Hellner, C., Bhagia, J., & Halldner, L. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09424-2 · Cited by 14
Metadata
- Authors
- Handen, B. L., Johnson, C. R., & Lubetsky, M.
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 2000-06
- Volume
- 30
- Issue
- 3
- Pages
- 245-255
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W1498586118
- Cited by
- 326
- References
- 34
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.